September 17, 2010 - The Cardiovascular Research Foundation's 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) symposium, to be held Sept. 21- 25, will feature presentations on Xience V data.
September 17, 2010 – The U.S. Food and Drug Administration (FDA) today expanded the indication for three cardiac resynchronization therapy defibrillators (CRT-D) to all classes of heart failure patients.
September 17, 2010 - Clinical uses will soon begin for the C3 Delivery System for the Gore Excluder Device as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm (AAA). The delivery system, made by W.L. Gore & Associates, provides surgeons with cannulation options and allows them to bring the contralateral gate to the contralateral guidewire.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 16, 2010 – A new collection of software applications for structural heart treatment under angiography will be highlighted by GE Healthcare during the 2010 Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C.
September 16, 2010 – The features of the Infinix-i angiography systems that make the radial access approach more successful will be highlighted at the Transcatheter Cardiovascular Therapeutics (TCT) symposium Sept. 21-25 in Washington, D.C.
September 15, 2010 – Results from the PARTNER Trial Cohort B will be presented at 11 a.m. on Thursday, Sept. 23, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific symposium in Washington, D.C.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
A new class of antiplatelet therapy drug pending U.S. Food and Drug Administration (FDA) clearance may offer greater benefits over clopidogrel (Plavix) the current standard of therapy. The new drug also offers the ability to have its effects reversed quickly.
Over the past five years, two major changes have occurred in cardiovascular information systems (CVIS) and cardiovascular picture archiving and communications systems (PACS). There is a migration from disparate reporting and imaging systems toward a single, unified system. The second trend is easier access to patient information using Web-based and cloud technology.
In this era of financial cost-cutting, questions are raised over the true need for 256- or 320-slice computed tomography (CT) systems for cardiac imaging. There are many radiologists and cardiologists who argue a 64-slice CT system is good enough to make a cardiac diagnosis without spending twice as much for the higher-slice systems.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Advancements in newer 64-slice computed tomography (CT) systems and the introduction of 256- and 320-slice systems are helping to significantly reduce exposure to ionizing radiation.
September 15, 2010 — As the result of a new partnership, the Image-Arena advanced visualization software will be integrated into the Impax cardiovascular picture archiving and communication system (PACS). Agfa HealthCare has signed an agreement with TomTec to add its Image-Arena solution into Agfa's Impax Cardiovascular.
September 15, 2010 – The U.S. Food and Drug Administration (FDA) granted 510(k) market approval for the Medivance noninvasive Arctic Sun 5000 therapeutic temperature management device. The new patient cooling device offers fast initiation of treatment, simple programming capabilities and easy access to treatment.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 15, 2010 – A study evaluating the level of platelet aggregation achieved after switching from clopidogrel (Plavix) 75 mg once-daily maintenance dosing plus aspirin to prasugrel (Effient) 10 mg once-daily maintenance dosing (MD) in patients with acute coronary syndrome (ACS) was published today in the Journal of the American College of Cardiology.
September 15, 2010 – The U.S. Food and Drug Administration (FDA) has extended the time to complete its review of the new drug application (NDA) for ticagrelor (Brilinta), which is the first reversible oral antiplatelet drug.
September 15, 2010 – A high-definition intravascular ultrasound (IVUS) system will be demonstrated during the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium Sept. 21-25 in Washington, D.C.